BIOTECanada
When CATTI burst onto the scene in 2021, it entered a rapidly expanding cell and gene therapy (CGT) industry struggling to keep up with talent requirements. Rising to the challenge, CellCAN, a knowledge mobilization network in CGTs, and CCRM, a leader in developing and commercializing regenerative medicine-based technologies and CGTs, launched CATTI last July. Today, CATTI offers more than 50 online courses in English and French that are fully stackable and user centric.
In Canada, bio-economy labour demand could exceed supply as soon as 2024 — with 65,000 additional workers required by 2029. While there’s no single magic solution to solving the shortage, increasing inclusion, diversity, equity and accessibility — IDEA — is critical.
“OmniaBio Inc. will be a game-changer for Ontario and Canada,” explains Dr. Michael May, CCRM President and CEO, and Chair of Omniabio Inc. “It will provide missing infrastructure to allow Ontario and Canadian cell and gene therapy companies to remain here, while also attracting foreign companies.
Canada has all of the right ingredients to ensure strong and sustainable healthcare into the future. The external environment in Canada has so much going for itself – smart people; diversity in our population; high education levels; strong innovation mindset; open culture of collaboration; good healthcare.
Ready-to-use potable water available in a new home is a basic need and an unconscious expectation of any home buyer in the developed world. Like potable water for a home, timely access to ready-to-use (RTU) data is fundamental and should be considered a basic need for digital transformation.
Canadian scientists have also been instrumental in discoveries related to the polio and Ebola vaccines, or that it was in a Canadian lab that a compound was developed to stunt HIV’s vicious rate of replication.
Cancer. We have big ambitions to develop personalized and potent treatments in areas of high unmet medical need.
"Don't Eat Me" It’s a simple biological message whispered by crafty cancer cells to the immune system as they attempt to spread, grow and avoid destruction.
We all know highly qualified, inspirational women fully capable of sitting on a corporate board. And yet, there is a general perception that the existing pool of experienced senior women on which to draw is simply too small, and that gender parity on corporate boards is, in fact, a “pipeline” problem.
As Canada’s leading science initiative, the Sanofi Biogenius Canada program encourages students to break barriers and explore real-life STEM (science, technology, engineering, and math) research ideas.
Facilities provide young companies with much needed exposure, mentorship, investor and business contacts, and a community for collaboration and innovation.
In a world seriously impacted both socially and economically by an ongoing global pandemic, governments quickly turned to the biotechnology sector for help in mounting a therapeutic response.
A central pillar of BIOTECanada’s narrative for the industry is the reality of a global population moving quickly to nine or ten billion people and the enormous pressure feeding, housing, healing, and fueling this population growth places on the environment and planet.
Sanofi is expanding its manufacturing footprint and building on its research and development initiatives to make more lifesaving vaccines available to Canadians, adults and children worldwide.
The past few years have been extremely rewarding as we’re finally seeing our dream become a reality with the commercialization of Arctic® apples.
A thriving life sciences sector in Canada needs to be nurtured and supported if we are to leverage and build on its recent successes
